CYCLOSPORINE-A AND TISSUE ANTIGEN MATCHING IN BONE TRANSPLANTATION - FIBULAR ALLOGRAFTS STUDIED IN THE DOG

被引:15
|
作者
WELTER, JF
SHAFFER, JW
STEVENSON, S
DAVY, DT
FIELD, GA
KLEIN, L
LI, XQ
ZIKA, JM
GOLDBERG, VM
机构
[1] Department of Orthopedics, Case Western Reserve University, Cleveland, OH, 44106
来源
ACTA ORTHOPAEDICA SCANDINAVICA | 1990年 / 61卷 / 06期
关键词
D O I
10.3109/17453679008993574
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
We studied the mechanical, metabolic, and histologic properties of short-term nonvascularized cortical bone grafts in a canine fibular graft model. Sham operated nonvascularized autotransplanted and allotransplanted bones were compared. The allografts were performed between dog leukocyte antigen (DLA) class I and II matched; DLA class I and II mismatched; and cyclosporin A (CsA) treated, DLA class I and II mismatched animals. Cyclosporin was given for 1 month, and all the animals were followed for 3 months after surgery. Mechanical properties were investigated using standard torsional tests, metabolic kinetics were assessed using isotopic prelabeling techniques, and histomorphometric analysis of cross-sectional area properties and sequential fluorochrome labels were performed. Autografts were mechanically stronger and stiffer than all the types of allograft. CsA-treated, DLA-mismatched allografts performed better than matched allografts. These in turn were stronger than non-CsA-treated, mismatched allografts, which underwent nearly complete resorption. These relationships were preserved in the metabolic and histologic analyses. In this short-term animal study, although DLA matching resulted in a slight improvement in graft outcome, mismatched grafts in dogs receiving a short course of cyclosporin A fared even better.
引用
收藏
页码:517 / 527
页数:11
相关论文
共 50 条
  • [41] Donor-Recipient Human Leukocyte Antigen Matching Practices in Vascularized Composite Tissue Allotransplantation: A Survey of Major Transplantation Centers
    Ashvetiya, Tamara
    Mundinger, Gerhard S.
    Kukuruga, Debra
    Bojovic, Branko
    Christy, Michael R.
    Dorafshar, Amir H.
    Rodriguez, Eduardo D.
    [J]. PLASTIC AND RECONSTRUCTIVE SURGERY, 2014, 134 (01) : 121 - 129
  • [42] A ROLE FOR NONSPECIFIC (CYCLOSPORINE-A) OR SPECIFIC (MONOCLONAL-ANTIBODIES TO ICAM-1, LFA-1, AND IL-10) IMMUNOMODULATION IN THE PROLONGATION OF SKIN ALLOGRAFTS AFTER ANTIGEN-SPECIFIC PRETRANSPLANT IMMUNIZATION OR TRANSFUSION
    GORCZYNSKI, RM
    WOJCIK, D
    [J]. JOURNAL OF IMMUNOLOGY, 1994, 152 (04): : 2011 - 2019
  • [43] HIV-1 GP120-DEPENDENT INDUCTION OF APOPTOSIS IN ANTIGEN-SPECIFIC HUMAN T-CELL CLONES IS CHARACTERIZED BY TISSUE TRANSGLUTAMINASE EXPRESSION AND PREVENTED BY CYCLOSPORINE-A
    AMENDOLA, A
    LOMBARDI, G
    OLIVERIO, S
    COLIZZI, V
    PIACENTINI, M
    [J]. FEBS LETTERS, 1994, 339 (03) : 258 - 264
  • [44] SYNERGISM OF INTERLEUKIN-2 AND CYCLOSPORINE-A IN INDUCTION OF A GRAFT-VERSUS-TUMOR EFFECT WITHOUT GRAFT-VERSUS-HOST DISEASE AFTER SYNGENEIC BONE-MARROW TRANSPLANTATION
    CHARAK, BS
    AGAH, R
    MAZUMDER, A
    [J]. BLOOD, 1992, 80 (01) : 179 - 184
  • [45] USE OF CAMPATH-1 AND CYCLOSPORINE-A (CSA) IN THE PROPHYLAXIS OF THE GRAFT-VERSUS-HOST DISEASE (GVHD) IN AN ALLOGENEIC BONE-MARROW TRANSPLANTATION (TMO) FOR CHRONIC MYELOID-LEUKEMIA (CML)
    ARCESE, WG
    BIANCHI, A
    MAURO, FR
    GALLERANO, T
    PASQUALETTI, D
    DEFELICE, L
    [J]. MEDICINA-RIVISTA DELLA ENCICLOPEDIA MEDICA ITALIANA, 1985, 5 (01): : 60 - 62
  • [46] CYCLOSPORINE-A INDUCES A SELECTIVE, REVERSIBLE SUPPRESSION OF T-HELPER LYMPHOCYTE REGENERATION AFTER SYNGENEIC BONE-MARROW TRANSPLANTATION - ASSOCIATION WITH SYNGENEIC GRAFT-VERSUS-HOST DISEASE IN RATS
    BOS, GMJ
    MAJOOR, GD
    VRIESMAN, PJCV
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1988, 74 (03): : 443 - 448
  • [47] Human leukocyte antigen supertype matching after myeloablative hematopoietic cell transplantation with 7/8 matched unrelated donor allografts: a report from the Center for International Blood and Marrow Transplant Research
    Lazaryan, Aleksandr
    Wang, Tao
    Spellman, Stephen R.
    Wang, Hai-Lin
    Pidala, Joseph
    Nishihori, Taiga
    Askar, Medhat
    Olsson, Richard
    Oudshoorn, Machteld
    Abdel-Azim, Hisham
    Yong, Agnes
    Gandhi, Manish
    Dandoy, Christopher
    Savani, Bipin
    Hale, Gregory
    Page, Kristin
    Bitan, Menachem
    Reshef, Ran
    Drobyski, William
    Marsh, Steven G. E.
    Schultz, Kirk
    Mueller, Carlheinz R.
    Fernandez-Vina, Marcelo A.
    Verneris, Michael R.
    Horowitz, Mary M.
    Arora, Mukta
    Weisdorf, Daniel J.
    Lee, Stephanie J.
    [J]. HAEMATOLOGICA, 2016, 101 (10) : 1267 - 1274
  • [48] POST TRANSPLANTATION DONOR-SPECIFIC BONE-MARROW TRANSFUSION IN POLYCLONAL ANTILYMPHOCYTE SERUM-TREATED RECIPIENTS - THE OPTIMAL CELLULAR ANTIGEN FOR INDUCTION OF UNRESPONSIVENESS TO ORGAN ALLOGRAFTS
    MONACO, AP
    WOOD, ML
    MAKI, T
    GOZZO, JJ
    [J]. TRANSPLANTATION PROCEEDINGS, 1988, 20 (06) : 1207 - 1212
  • [49] Graft versus host disease prophylaxis with low-dose cyclosporine-A reduces the risk of relapse in children with acute leukemia given HLA-identical sibling bone marrow transplantation: results of a randomized trial
    Locatelli, F
    Zecca, M
    Rondelli, R
    Bonetti, F
    Dini, G
    Prete, A
    Messina, C
    Uderzo, C
    Ripaldi, M
    Porta, F
    Giorgiani, G
    Giraldi, E
    Pession, A
    [J]. BLOOD, 2000, 95 (05) : 1572 - 1579
  • [50] CAMPATH-1(CP-1) AND CYCLOSPORINE-A (CYA) TO PREVENT GRAFT-VERSUS-HOST DISEASE (GVHD) IN ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC MYELOID-LEUKEMIA (CML)
    ARCESE, W
    PAPA, G
    AMADORI, S
    BIANCHI, A
    MAURO, FR
    MALAGNINO, F
    PASQUALETTI, D
    DEFELICE, D
    DIVERIO, D
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 192 - 192